Pure Global
NCT06308562

Fuzzy Wale Compression Stockinet to Promote Healing Following Transtibial Amputation for Peripheral Arterial Disease

A Pilot Study of Fuzzy Wale Compression Stockinet to Evaluate Healing Following Transtibial Amputation for Peripheral Arterial Disease
Mayo Clinic·ClinicalTrials.gov·device·Device trialNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Peripheral Arterial Disease
Drug/Device/Intervention
Fuzzy Wale Compression Stockinet
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Mayo Clinic
Location
Rochester, United States of America
Timeline & enrollment
Phase
N/A
Start date
Jun 01, 2024
End date
Aug 01, 2024
Enrollment
40 participants
Primary outcome

Surgical site infection,Wound dehiscence,Days on negative pressure wound therapy,Pain control,Time to prosthetic fitting

Summary

The objective of this study is to determine if using Fuzzy Wale compression stockinett can
 assist in reducing the healing time and decrease costs in trastibial amputation patients as
 compared to standard of care treatment compression stocking.

ICD-10 classifications
Peripheral vascular disease, unspecifiedOther peripheral vascular diseasesOther specified peripheral vascular diseasesPeripheral angiopathy in diseases classified elsewhereOther congenital malformations of peripheral vascular system
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06308562
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06308562 through Pure Global AI's free database. This phase not specified trial is sponsored by Mayo Clinic and is currently Not yet recruiting. The study focuses on Peripheral Arterial Disease. Target enrollment is 40 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.